OMR, A POSITIVE BOWEL CONTRAST AGENT FOR ABDOMINAL AND PELVIC MR IMAGING - SAFETY AND IMAGING CHARACTERISTICS

被引:19
作者
PATTEN, RM
MOSS, AA
FENTON, TA
ELLIOTT, S
机构
[1] Department of Radiology, University of Washington School of Medicine, Seattle
来源
JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING | 1992年 / 2卷 / 01期
关键词
ABDOMEN; MR; CONTRAST ENHANCEMENT; INTESTINES; IRON;
D O I
10.1002/jmri.1880020105
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
To determine the safety and imaging characteristics of OMR-an effervescent solution of ferric ammonium citrate-as a bowel contrast agent, magnetic resonance (MR) imaging at 1.5 T was performed in 29 volunteers. T1- and T2-weighted images of the upper abdomen and pelvis were obtained before and after oral administration of OMR at doses of 100-400 mg of iron in 300-600 mL of water. Respiratory-ordered phase encoding and presaturation pulses were used routinely for artifact suppression. All dose levels of OMR provided marking of the bowel by increasing intraluminal signal intensity; however, the degree and percentage of small bowel opacification appeared more prominent at higher dose levels of iron. Semisolid or watery bowel movements were noted in 31% of subjects, but no clinically important laboratory abnormalities were seen. OMR improved delineation of the head of the pancreas on T1-weighted images in 72% of subjects but was less useful in defining the body and tail. OMR is a safe and effective bowel contrast agent for MR imaging. Because artifacts due to movement of hyperintense bowel may degrade the images, OMR may be most useful on short TR/TE or fast imaging pulse sequences or when combined with antiperistaltic agents.
引用
收藏
页码:25 / 34
页数:10
相关论文
共 17 条
[1]  
Wesbey GE, Brasch RC, Engelstad BL, Moss AA, Brito AC, Nuclear magnetic resonance contrast enhancement study of the gastrointestinal tract of rats and a human volunteer using nontoxic oral iron solutions, Radiology, 149, pp. 175-180, (1983)
[2]  
Wesbey GE, Brasch RC, Goldberg HI, Engelstad BL, Moss AA, Dilute oral iron solutions as gastrointestinal contrast agents for magnetic resonance imaging: initial clinical experience, Magn Reson Imaging, 3, pp. 57-64, (1985)
[3]  
Mattrey RF, Hajek PC, Gylys-Morin VM, Et al., Perfluoro‐chemicals as gastrointestinal contrast agents for MR imaging: preliminary studies in rats and humans, AJR, 148, pp. 1259-1263, (1987)
[4]  
Laniado M, Kornmesser W, Hamm B, Clauss W, Weinmann HJ, Felix R, MR imaging of the gastrointestinal tract: value of Gd‐DTPA, AJR, 150, pp. 817-821, (1988)
[5]  
Idder DL, Edelman RR, Grief WL, Monda L, Magnetite albumin suspension: a superparamagnetic oral MR contrast agent, AJR, 147, pp. 839-843, (1987)
[6]  
Hahn PF, Stark DD, Saini S, Lewis JM, Wittenberg J, Fer-rucci JT, Ferrite particles for bowel contrast in MR imaging: design issues and feasibility studies, Radiology, 164, pp. 37-41, (1987)
[7]  
Lonnemark M, Hemmingson A, Bach-Gansmo T, Et al., Effect of superparamagnetic particles as oral contrast media at magnetic resonance imaging: a phase I clinical study, Acta Radiol, 30, pp. 193-196, (1989)
[8]  
Hahn PF, Stark DD, Lewis JM, Et al., First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging, Radiology, 175, pp. 695-700, (1990)
[9]  
Kaminsky S, Laniado M, Gogoll M, Et al., Gadopentetate dimeglumine as a bowel contrast agent: safety and efficacy, Radiology, 178, pp. 503-508, (1991)
[10]  
Rinck PA, Smevik O, Nilsen G, Et al., Oral magnetic particles in MR imaging of the abdomen and pelvis, Radiology, 178, pp. 775-779, (1991)